GEN Exclusives

More »

GEN News Highlights

Back to Item »

Cytos Makes 80% Workforce Cut and Halts All In House Programs Except Lead Allergy Drug

Firm will focus on Phase II-stage Cyt003-QbG10 candidate and continue with Pfizer and Novartis-partnered programs.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Why Some People Are Anti-GMO?

Do you think GMOs would be viewed more favorably if more attention was paid to the resulting product rather than the GMO technology used to produce it?

More »